PRZOOM - /newswire/ -
St Neots, Cambridgeshire, United Kingdom, 2012/06/07 - Tecan has signed a co-marketing agreement with Reinnervate, a leading company in the 3D cell culture market.
Tecan has signed a co-marketing agreement with Reinnervate to develop a range of automated solutions based on the Freedom EVO® liquid handling workstations and Reinnervate’s Alvetex®Scaffold 3D cell culturing technology.
Alvetex products are based on a highly porous, polystyrene scaffold structure with a uniform and well-defined architecture, providing an excellent environment for cells to acquire and maintain their natural three-dimensional shape and organization during incubation that leads to more biologically relevant data. This technology overcomes the limitations of traditional monolayer cultures and, combined with the flexibility and reliability of the Freedom EVO platform, will provide a powerful solution for automated growth and maintenance of 3D cell cultures, allowing customers to develop more reliable and powerful cellular assays.
Kevin Moore, Head of Applications and Solutions at Tecan, said: “We are delighted to be working with Reinnervate and look forward to combining our mutual expertise and technical abilities to develop ground-breaking solutions for cell biology customers.”
Richard Rowling, Commercial Director at Reinnervate added: “We are delighted that Tecan has decided to put Alvetex Scaffold at the heart of its plans for the automation of 3D cell culture. Alvetex is becoming the industry standard for scientists who need to retain the native structure and functionality of cells, to better mimic in vivo biological models.”
To find out more about Tecan’s cell biology solutions, visit tecan.com/cellbiology To find out more about Alvetex products, visit reinnervate.com/.
For more information please contact
Tecan Trading AG Cornelia Kegele / Antonietta Allocca Seestrasse 103, CH-8708 Männedorf Tel +41 (0)44 922 81 11, Fax +41 (0)44 922 81 12 info[.]tecan.com tecan.com
Tecan (tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2011, Tecan generated sales of CHF 377 million (USD 424 million; EUR 306 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).